Search - tctmd.com

Displaying 1 - 20 of 242

Sort: Relevancy | Date

News Daily News

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

L.A. McKeown

February 04, 2026

News Daily News

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

Todd Neale

December 26, 2025

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

L.A. McKeown

December 23, 2025

Presentation TCT 2025

TCT 927: Long-term prognostic value of post-revascularization fractional flow reserve and skin perfusion toe pressure in patients with critical limb ischaemia

Presenter: Zoltan Ruzsa

October 28, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

Presentation TCT 2025

TCT 922: Duration-Dependent Outcomes of Dual Antiplatelet Therapy Following Peripheral Endovascular Revascularization: A Systematic Review and Meta-Analysis of Target Vessel Patency, Limb Salvage, and Safety Events

Presenter: Zeyad Kholeif

October 26, 2025

Presentation TCT 2025

INCORPORATE-EXTENDED: Two-Center Long-Term Outcomes of an Intentional Invasive vs Conservative Coronary Strategy After Critical Limb Ischemia Revascularization

Presenter: Sadeek Sidney Kanoun Schnur

October 26, 2025

News Conference News ESC 2025

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

L.A. McKeown

September 05, 2025

News Conference News ESC 2025

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC

Todd Neale

September 01, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Conference News EuroPCR 2025

Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data

Yael L. Maxwell

May 20, 2025

News Conference News CX Symposium 2025

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

L.A. McKeown

April 30, 2025

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Conference News THT 2025

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Todd Neale

February 14, 2025

News Daily News

Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many

L.A. McKeown

January 16, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

L.A. McKeown

November 06, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

Advertisement

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

December 2025 Dispatch for the CV Team

TCT 927: Long-term prognostic value of post-revascularization fractional flow reserve and skin perfusion toe pressure in patients with critical limb ischaemia

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

TCT 922: Duration-Dependent Outcomes of Dual Antiplatelet Therapy Following Peripheral Endovascular Revascularization: A Systematic Review and Meta-Analysis of Target Vessel Patency, Limb Salvage, and Safety Events

INCORPORATE-EXTENDED: Two-Center Long-Term Outcomes of an Intentional Invasive vs Conservative Coronary Strategy After Critical Limb Ischemia Revascularization

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many

Top Endovascular News of 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content